ArticlePolymers2022
Preparation of 3D Printed Polylactic Acid/Bacterial Cellulose Composite Scaffold for Tissue Engineering Applications.
Article in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.
- Applications of Bacterial Cellulose-Based Composite Materials in Hard Tissue Regenerative Medicine.Tissue engineering and regenerative medicine · 2023Pooled it
- Recent advances in bioengineering and functional applications of microbial biocomposites: integrating bacterial cellulose, fungal mycelium and synthetic biology.World journal of microbiology & biotechnology · 2026Review
- Role of cellulose and its derivatives for 3D printing of bone tissue scaffolds.Frontiers in bioengineering and biotechnology · 2026Review
- Bacterial Cellulose: A Sustainable Source for Hydrogels and 3D-Printed Scaffolds for Tissue Engineering.Gels (Basel, Switzerland) · 2024Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
Abstract
Bacterial cellulose (BC) has become a universal biomaterial owing to its intrinsic properties. BC fibers are composed of microfibers with a diameter of 3-4 nm into fiber bundles with a thickness of 40-60 nm, and interweave with each other to form a well-developed ultra-fine network structure. Polylactic acid (PLA) has good mechanical properties and excellent biocompatibility and biodegradability. Therefore, PLA has been widely applied in tissue engineering. Addressed herein is a novel type of PLA/BC (PLA/BC) composite scaffold prepared by 3D printing (3D), 3D modeling of the required porous membrane material support established in the computer, and decomposition of the model into 5 layer 20 μM sheets. The range of PLA loadings assessed in this work was 1.0 wt.%, 1.5 wt.%, and 2.0 wt.%, and its physicochemical properties and biological properties were characterized and evaluated. Tensile strength of PLA/BC composite scaffolds increased to 66.49 MPa compared to that of a pure BC film (25.61 MPa). Hydrophilicity was tunable with the amount of added PLA. In this paper, the effects of 3D round hole and stripe surface topology on cell growth behavior were characterized. Schwann cells (SCs) adhered to the surface of the 3D composite membrane successfully, and their proliferation rate on the surface of the regular circular pore and stripe structure was better than that of the smooth surface. Erythrocyte fixation and platelet adhesion experiments showed that the 3D composite scaffold had excellent blood compatibility. Further degradation studies showed that loose structures appeared after 1 week, and structural defects began after 3 weeks. The in vitro degradation results showed that the degradation rate of the BC membrane in simulated body fluid after 6 weeks was 14.38%, while the degradation rate of the PLA/BC composite scaffold was 18.75%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.